Deferred Tax Assets, Valuation Allowance of BIODESIX INC from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BIODESIX INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • BIODESIX INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $106,525,000, a 7.6% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BIODESIX INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $106,525,000 +$7,532,000 +7.6% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $98,993,000 +$5,970,000 +6.4% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $93,023,000 +$10,471,000 +13% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q4 2022 $82,552,000 +$15,095,000 +22% 31 Dec 2022 10-K 01 Mar 2024 2023 FY
Q4 2021 $67,457,000 +$11,374,000 +20% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q4 2020 $56,083,000 +$4,948,000 +9.7% 31 Dec 2020 10-K 14 Mar 2022 2021 FY
Q4 2019 $51,135,000 31 Dec 2019 10-K 16 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.